What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?
Myocardial ischemia-reperfusion injury (MIRI), the joint result of ischemic injury and reperfusion injury, is associated with poor outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Accumulating evidence demonstrates that activated platelets directly contribute to the pathogenesis of MIRI through participating in the formation of microthrombi, interaction with leukocytes, secretion of active substances, constriction of microvasculature, and activation of spinal afferent nerves.
Source: Thrombosis Research - Category: Hematology Authors: Lun Wang, Yifan Liu, Ran Tian, Wei Zuo, Hao Qian, Liang Wang, Xinglin Yang, Zhenyu Liu, Shuyang Zhang Tags: Review Article Source Type: research
More News: Angioplasty | Coronary Angioplasty | Heart Attack | Hematology | Percutaneous Coronary Intervention | Thrombosis